Zeke Capital Advisors, LLC Ironwood Pharmaceuticals Inc Transaction History

Zeke Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$11.05 - $12.72 $313,212 - $360,548	-28,345 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$10.61 - $12.88 $59,638 - $72,398	5,621 Added 24.74%	28,345 $357,000
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $18,690 - $24,007	1,721 Added 8.19%	22,724 $265,000
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $20,740 - $24,220	1,740 Added 9.03%	21,003 $274,000
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $52,191 - $67,346	5,137 Added 36.37%	19,263 $248,000

Q4 2020 Feb 10, 2021	BUY	$9.05 - $12.2 $127,840 - $172,337	14,126 New	14,126 $161,000

296

170M

27.1M

2.28M

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $953M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.